Introduction to Testicular Cancer

  • Gerasimos J. AlivizatosEmail author
  • Pavlos A. Pavlakis


In this chapter, all the contributors will analyze the latest developments of all imaging modalities that are used today in order to offer the correct information to urologists and oncologists who treat men with testicular cancer. Correct information leads to correct decisions upon further chemotherapy and upon surgical procedures, and all these difficult decisions have the purpose to avoid unnecessary therapies that might hamper the quality of life of our patients.


Testicular cancer Imaging modalities Computerized tomography (CT) Magnetic resonance imaging (mri) Positron emission tomography (PET) 


  1. 1.
    La Vecchia C, Bosetti C, Lucchini F et al (2010) Cancer mortality in Europe, 2000–2004, and an overview of trends since 1995. Ann Oncol 21(6):1323–1360CrossRefGoogle Scholar
  2. 2.
    Cancer incidence in five continents (2007). In: Curado MP, Edwards B, Shin R, et al (eds) IARC Scientific, vol IX. Publication No. 160Google Scholar
  3. 3.
    Mannuel H, Mitikiri N, Khan M et al (2012) Testicular germ cell tumors: biology and clinical update. Curr Opin Oncol 24(3):266–271CrossRefGoogle Scholar
  4. 4.
    Tummala M, Hussain A (2008) Recent developments in germ cell tumors. Curr Opin Oncol 20(3):287–293CrossRefGoogle Scholar
  5. 5.
    Albers P, Albercht W, Algaba F et al (2011) EAU guidelines on testicular cancer: 2011 update. Eur Urol 60(2):304–319CrossRefGoogle Scholar
  6. 6.
    Morarles-Barrera R, Valverde C, Rodon J et al (2010) Bilateral testicular germ cell tumors: a single hospital experience. Clin Trans Oncol 12(4):299–302CrossRefGoogle Scholar
  7. 7.
    Fleming J, Cooper J, Henson D et al (1997) Testis. In: American joint committee on cancer staging manual, 5th edn. Lippincot-Raven, PhiladelphiaGoogle Scholar
  8. 8.
    International Germ Cell Collaborative Group (1997) International germ cell consensus classification: a prognostic factor based staging system for metastatic germ cell cancers. J Clin Oncol 15(2):594–603CrossRefGoogle Scholar
  9. 9.
    Kim W, Rosen MA, Langer JE et al (2007) US-MR imaging correlation in pathologic conditions of the scrotum. Radiographics 27(5):1239–1253CrossRefGoogle Scholar
  10. 10.
    Cassidy FH, Ishioka KM, McMahon CJ et al (2010) MR imaging of scrotal tumors and pseudotumors. Radiographics 30(3):665–683CrossRefGoogle Scholar
  11. 11.
    Husband JE, Barrett A, Peckham MJ (1981) Evaluation of computed tomography in the management of testicular teratoma. Br J Urol 53(2):179–183CrossRefGoogle Scholar
  12. 12.
    Ellis JH, Blies JR, Kopecky KK et al (1984) Comparison of NMR and CT imaging in the evaluation of metastatic retroperitoneal lymphadenopathy from testicular carcinoma. J Comput Assist Tomogr 8(4):709–719CrossRefGoogle Scholar
  13. 13.
    Oechsle K, Hartmann M, Brenner W et al (2008) German multicenter positron emission tomography study group. 18F Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group. J Clin Oncol 26(36):5930–5935CrossRefGoogle Scholar
  14. 14.
    Winter C, Pfister D, Busch J et al (2012) Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German testicular cancer study group. Eur Urol 61(2):403–409CrossRefGoogle Scholar
  15. 15.
    De Santis M, Becherer A, Bokemeyer C et al (2004) Pont J. 2–18fluoro-deoxy-d-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 22(6):1034–1039CrossRefGoogle Scholar
  16. 16.
    Daneshmand S, Albers P, Fossa A et al (2012) Contemporary management of postchemotherapy testis cancer. Eur Urol 62(5):867–876CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.3rd Urological DepartmentHygeia HospitalAthensGreece

Personalised recommendations